Notice of Completion of Consolidation Procedures of Shanghai Hongqiao Traditional Chinese Drug Pieces Co., Ltd.11/10TDnetPDF(140KB)
Notice regarding revision (upward revision) of numerical targets in the Medium-Term Management Plan11/10TDnetPDF(120KB)
Notice Regarding Revision of Earnings Forecast and Revision of Dividend Forecast (Dividend Increase)11/10TDnetPDF(158KB)
Consolidated Financial Results for the Six Months Ended September 30, 2025 (Under Japanese GAAP)11/10TDnetPDF(432KB)
Notice Regarding Additional Contributions Accompanying the Continuation of the Performance-Based Stock Compensation System8/27TDnetPDF(124KB)
Notice regarding additional contributions related to the continuation of Trust-type Stock Delivery System for Employees8/26TDnetPDF(123KB)
Consolidated Financial Results for the First Quarter of the Term Ending March 31, 20268/5TDnetPDF(350KB)
Notice regarding the conclusion of an agreement for Tsumura China Inc. to acquire an interest in Shanghai Hongqiao Traditional Chinese Drug Pieces Co.6/18TDnetPDF(187KB)